CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 92 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Krop Julie Director | Option exercise 10b5-1 | +25,000 | $0.71 | $18K | 25,000 |
| 2026-06-23 | Krop Julie Director | Sale 10b5-1 | −25,000 | $5.02 | $125K | 0 |
| 2026-06-23 | Krop Julie Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −25,000 | 0 | ||
| 2026-06-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.16 | $104K | 635,574 |
| 2026-06-10 | MORRIS TIMOTHY E Director | Grant or award · Stock Option (right to purchase) | +50,500 | 50,500 | ||
| 2026-06-10 | Krop Julie Director | Grant or award · Stock Option (Right to Purchase) | +50,500 | 50,500 | ||
| 2026-06-10 | Jenkins Abigail L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | −50,500 | 50,500 | ||
| 2026-06-10 | Cochran John Director | Grant or award · Stock Option (Right to Purchase) | +50,500 | 50,500 | ||
| 2026-06-10 | BROWN GREGORY B Director | Grant or award · Stock Option (Right to Purchase) | +50,500 | 50,500 | ||
| 2026-06-10 | Taglietti Marco Director | Grant or award · Stock Option (Right to Purchase) | +50,500 | 50,500 | ||
| 2026-06-08 | Korczynski Sherry Chief Commercial Officer | Shares withheld for taxes | −2,714 | 238,403 | ||
| 2026-05-18 | Zalewski Thomas A. Chief Legal Officer | Grant or award | +100,000 | 100,000 | ||
| 2026-05-18 | Zalewski Thomas A. Chief Legal Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-05-15 | Barber Daniel President and CEO | Sale 10b5-1 | −8,257 | $4.29 | $35K | 660,574 |
| 2026-05-15 | Cioffi Melina SVP, Regulatory Affairs | Shares withheld for taxes | −1,667 | $4.17 | $7K | 273,200 |
| 2026-05-07 | BRAENDER LORI J Corporate Secretary | Shares withheld for taxes | −135,690 | $4.23 | $574K | 231,042 |
| 2026-05-05 | Boyd Peter E. Chief People Officer | Shares withheld for taxes | −56,778 | $4.18 | $237K | 281,731 |
| 2026-05-05 | Barber Daniel President and CEO | Shares withheld for taxes | −335,922 | $4.18 | $1.4M | 668,831 |
| 2026-05-05 | TOTH A ERNEST JR Chief Financial Officer | Shares withheld for taxes | −92,652 | $4.18 | $387K | 283,460 |
| 2026-05-05 | Jung Cassie Chief Operating Officer | Shares withheld for taxes | −72,734 | $4.18 | $304K | 202,246 |
Page 2 of 15 · 300 trades